Sign inJoin waitlistJoin the waitlist

Ioana Bonta

Physician · Northside Hospital

Credentials: · · · ·

History

Northside Hospital
2019–Present

Hematology and Medical Oncology
Emory University School of Medicine
2011–2014
Internal Medicine
1996–1999
Doctor of Medicine
1992–1996

Research

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology · 2018 · 121 citations
Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location
Medical Physics · 2004 · Last of 7 authors · 56 citations
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC:…
Journal of Thoracic Oncology · 2024 · Last of 10 authors · 32 citations

Aaron Mansfield
1 paper
AD
Anastasios Dimou
1 paper
Anjali Bharne
1 paper
Ben Creelan
1 paper
CH
Christian Hyde
1 paper
Christopher Parks
1 paper
DC
Dan Costin
1 paper
Daniel Miller
1 paper
JK
Jason Kaplan
1 paper
Jeffrey Ross
1 paper
JS
Jeffrey Silberberg
1 paper
Joaquina Baranda
1 paper

Clinical trials

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2023–2028
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2019–2029